CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.22

EPS Forecast

$7.06

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
DNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncNVAXNovavax IncREPLReplimune Group IncRGENRepligen CorpTECHBio-techne CorpMRNAModerna Inc